A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events – Reduction of Cholesterol to Key European Targets Trial

Alistair S. Hall, Beryl M. Jackson, Amanda Farrin, Maria Efthymiou, Julian H. Barth, Joanne Copeland, Kristian Bailey, Simon P.R. Romaine, Anthony J. Balmforth, Terry McCormack,

European Journal of Cardiovascular Prevention & Rehabilitation · 2009 · 25 citations · 31 references

DOIFull text

Open access

Abstract

We observed no superiority of either treatment for the ESC-03 lipid targets. Rosuvastatin 10 mg lowered mean cholesterol more effectively than simvastatin and achieved better results for the latest, more stringent, ESC target.

References

31